{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:34:24Z","timestamp":1790264064751,"version":"4.1.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41584-025-01348-0","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:37:30Z","timestamp":1768991850000},"page":"185-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inflammation and pain as interconnected targets in axial spondyloarthritis"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9362","authenticated-orcid":false,"given":"Xenofon","family":"Baraliakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-852X","authenticated-orcid":false,"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-7678","authenticated-orcid":false,"given":"Nelly","family":"Ziade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4537-6015","authenticated-orcid":false,"given":"Denis","family":"Poddubnyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"1348_CR1","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/ard-2023-225185","volume":"83","author":"D van der Heijde","year":"2024","unstructured":"van der Heijde, D. et al. Goodbye to the term \u2018ankylosing spondylitis\u2019, hello \u2018axial spondyloarthritis\u2019: time to embrace the ASAS-defined nomenclature. Ann. Rheum. Dis. 83, 547\u2013549 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR2","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1001\/jama.1977.03270510035017","volume":"237","author":"A Calin","year":"1977","unstructured":"Calin, A., Porta, J., Fries, J. F. & Schurman, D. J. Clinical history as a screening test for ankylosing spondylitis. JAMA 237, 2613\u20132614 (1977).","journal-title":"JAMA"},{"key":"1348_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/art.21619","volume":"54","author":"M Rudwaleit","year":"2006","unstructured":"Rudwaleit, M., Metter, A., Listing, J., Sieper, J. & Braun, J. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 54, 569\u2013578 (2006).","journal-title":"Arthritis Rheum."},{"key":"1348_CR4","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/ard.2008.101501","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper, J. et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann. Rheum. Dis. 68, 784\u2013788 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/1744666X.2024.2400294","volume":"21","author":"N Horbal","year":"2025","unstructured":"Horbal, N. & Maksymowych, W. P. Nociplastic pain in axial spondyloarthritis and psoriatic arthritis: role of JAK kinases in immunopathology and therapeutic impact of JAK inhibitors. Expert Rev. Clin. Immunol. 21, 137\u2013152 (2025).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"1348_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.rdc.2021.01.001","volume":"47","author":"D Minhas","year":"2021","unstructured":"Minhas, D. & Clauw, D. J. Pain mechanisms in patients with rheumatic diseases. Rheum. Dis. Clin. North. Am. 47, 133\u2013148 (2021).","journal-title":"Rheum. Dis. Clin. North. Am."},{"key":"1348_CR7","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen, S. P., Vase, L. & Hooten, W. M. Chronic pain: an update on burden, best practices, and new advances. Lancet 397, 2082\u20132097 (2021).","journal-title":"Lancet"},{"key":"1348_CR8","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/acr.25104","volume":"75","author":"AE Murphy","year":"2023","unstructured":"Murphy, A. E., Minhas, D., Clauw, D. J. & Lee, Y. C. Identifying and managing nociplastic pain in individuals with rheumatic diseases: a narrative review. Arthritis Care Res. 75, 2215\u20132222 (2023).","journal-title":"Arthritis Care Res."},{"key":"1348_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11926-017-0681-5","volume":"19","author":"D Poddubnyy","year":"2017","unstructured":"Poddubnyy, D. & Sieper, J. Mechanism of new bone formation in axial spondyloarthritis. Curr. Rheumatol. Rep. 19, 55 (2017).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1348_CR10","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper, J. et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann. Rheum. Dis. 68, ii1\u2013ii44 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR11","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.3899\/jrheum.160594","volume":"43","author":"D Poddubnyy","year":"2016","unstructured":"Poddubnyy, D. et al. Physical function and spinal mobility remain stable despite radiographic spinal progression in patients with ankylosing spondylitis treated with TNF-\u03b1 inhibitors for up to 10 years. J. Rheumatol. 43, 2142\u20132148 (2016).","journal-title":"J. Rheumatol."},{"key":"1348_CR12","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles, M. A. et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397, 2098\u20132110 (2021).","journal-title":"Lancet"},{"key":"1348_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.11.006","volume":"52","author":"SC Kieskamp","year":"2022","unstructured":"Kieskamp, S. C. et al. Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. Semin. Arthritis Rheum. 52, 151933 (2022).","journal-title":"Semin. Arthritis Rheum."},{"key":"1348_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11845-022-02957-4","volume":"192","author":"I Aykurt Karl\u0131bel","year":"2023","unstructured":"Aykurt Karl\u0131bel, I. & Kasapo\u011flu Aksoy, M. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis. Ir. J. Med. Sci. 192, 481\u2013489 (2023).","journal-title":"Ir. J. Med. Sci."},{"key":"1348_CR15","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4078\/jrd.2023.0009","volume":"30","author":"S Sas","year":"2023","unstructured":"Sas, S., Cengiz, G. & Kaplan, H. The effect of central sensitization on disease activity measures, quality of life and clinical parameters in axial spondyloarthritis: a cross-sectional study. J. Rheum. Dis. 30, 176\u2013184 (2023).","journal-title":"J. Rheum. Dis."},{"key":"1348_CR16","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00296-023-05317-2","volume":"43","author":"A Sariyildiz","year":"2023","unstructured":"Sariyildiz, A., Coskun Benlidayi, I., Turk, I., Zengin Acemoglu, S. S. & Unal, I. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis. Rheumatol. Int. 43, 923\u2013932 (2023).","journal-title":"Rheumatol. Int."},{"key":"1348_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/mr\/roab110","volume":"32","author":"FN Y\u00fccel","year":"2022","unstructured":"Y\u00fccel, F. N. & Duru\u00f6z, M. T. Central sensitization in axial spondyloarthritis: an explorative study with quantitative sensory testing and clinical scales. Mod. Rheumatol. 32, 1137\u20131145 (2022).","journal-title":"Mod. Rheumatol."},{"key":"1348_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00296-020-04621-5","volume":"40","author":"GT Jones","year":"2020","unstructured":"Jones, G. T., Mallawaarachchi, B., Shim, J., Lock, J. & Macfarlane, G. J. The prevalence of fibromyalgia in axial spondyloarthritis. Rheumatol. Int. 40, 1581\u20131591 (2020).","journal-title":"Rheumatol. Int."},{"key":"1348_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/ard-2023-225327","volume":"83","author":"DJ Clauw","year":"2024","unstructured":"Clauw, D. J. From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here? Ann. Rheum. Dis. 83, 1421\u20131427 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR20","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/art.41171","volume":"72","author":"D Dutta","year":"2020","unstructured":"Dutta, D. et al. Heritability of the fibromyalgia phenotype varies by age. Arthritis Rheumatol. 72, 815\u2013823 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1017\/S0033291708003784","volume":"39","author":"K Kato","year":"2009","unstructured":"Kato, K., Sullivan, P. F., Evengard, B. & Pedersen, N. L. A population-based twin study of functional somatic syndromes. Psychol. Med. 39, 497\u2013505 (2009).","journal-title":"Psychol. Med."},{"key":"1348_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0022-3999(04)00080-7","volume":"57","author":"JM Glass","year":"2004","unstructured":"Glass, J. M. et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J. Psychosom. Res. 57, 391\u2013398 (2004).","journal-title":"J. Psychosom. Res."},{"key":"1348_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41582-024-00966-8","volume":"20","author":"CM Kaplan","year":"2024","unstructured":"Kaplan, C. M. et al. Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms. Nat. Rev. Neurol. 20, 347\u2013363 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1348_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13075-024-03365-y","volume":"26","author":"S Tsiami","year":"2024","unstructured":"Tsiami, S. et al. Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia. Arthritis Res. Ther. 26, 141 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"1348_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-004009","volume":"10","author":"F Al Mohamad","year":"2024","unstructured":"Al Mohamad, F. et al. Association of nociplastic and neuropathic pain components with the presence of residual symptoms in patients with axial spondyloarthritis receiving biological disease-modifying antirheumatic drugs. RMD Open 10, e004009 (2024).","journal-title":"RMD Open"},{"key":"1348_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00393-019-0654-3","volume":"79","author":"TW Kim","year":"2020","unstructured":"Kim, T. W., Son, S. M. & Lee, J. S. Neuropathic pain in ankylosing spondylitis: a meta-analysis. Z. Rheumatol. 79, 95\u2013102 (2020).","journal-title":"Z. Rheumatol."},{"key":"1348_CR27","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/14397595.2020.1754322","volume":"31","author":"P Borman","year":"2021","unstructured":"Borman, P., Kaygisiz, F. & Yaman, A. Neuropathic component of low back pain in patients with ankylosing spondylitis. Mod. Rheumatol. 31, 462\u2013467 (2021).","journal-title":"Mod. Rheumatol."},{"key":"1348_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun, J. et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 38, 499\u2013505 (1995).","journal-title":"Arthritis Rheum."},{"key":"1348_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal. Transduct. Target. Ther. 8, 207 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1348_CR30","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1348_CR31","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1056\/NEJMra1909094","volume":"385","author":"G Schett","year":"2021","unstructured":"Schett, G., McInnes, I. B. & Neurath, M. F. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N. Engl. J. Med. 385, 628\u2013639 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1348_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152611","volume":"71","author":"J Braun","year":"2025","unstructured":"Braun, J., Sieper, J. & Dougados, M. The history of ankylosing spondylitis\/axial spondyloarthritis \u2014 what is the driving force of new knowledge? Semin. Arthritis Rheum. 71, 152611 (2025).","journal-title":"Semin. Arthritis Rheum."},{"key":"1348_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2023.101858","volume":"37","author":"X Baraliakos","year":"2023","unstructured":"Baraliakos, X., Kiltz, U., Kononenko, I. & Ciurea, A. Treatment overview of axial spondyloarthritis in 2023. Best. Pract. Res. Clin. Rheumatol. 37, 101858 (2023).","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"1348_CR34","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/annrheumdis-2019-215356","volume":"78","author":"DG McGonagle","year":"2019","unstructured":"McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J. & Moots, R. The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies. Ann. Rheum. Dis. 78, 1167\u20131178 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622770","volume":"12","author":"A Ceribelli","year":"2021","unstructured":"Ceribelli, A. et al. Clinical trials supporting the role of the IL-17\/IL-23 axis in axial spondyloarthritis. Front. Immunol. 12, 622770 (2021).","journal-title":"Front. Immunol."},{"key":"1348_CR36","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","volume":"13","author":"G Schett","year":"2017","unstructured":"Schett, G. et al. Enthesitis: from pathophysiology to treatment. Nat. Rev. Rheumatol. 13, 731\u2013741 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1348_CR37","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1002\/art.37695","volume":"64","author":"F Richter","year":"2012","unstructured":"Richter, F. et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum. 64, 4125\u20134134 (2012).","journal-title":"Arthritis Rheum."},{"key":"1348_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102429","volume":"19","author":"JMG Ruiz de Morales","year":"2020","unstructured":"Ruiz de Morales, J. M. G. et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: an updated review of the evidence focusing in controversies. Autoimmun. Rev. 19, 102429 (2020).","journal-title":"Autoimmun. Rev."},{"key":"1348_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cyto.2008.12.024","volume":"46","author":"SH Chang","year":"2009","unstructured":"Chang, S. H. & Dong, C. IL-17F: regulation, signaling and function in inflammation. Cytokine 46, 7\u201311 (2009).","journal-title":"Cytokine"},{"key":"1348_CR40","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1523\/JNEUROSCI.22-08-03052.2002","volume":"22","author":"S Shamash","year":"2002","unstructured":"Shamash, S., Reichert, F. & Rotshenker, S. The cytokine network of Wallerian degeneration: tumor necrosis factor-\u03b1, interleukin-1\u03b1, and interleukin-1\u03b2. J. Neurosci. 22, 3052\u20133060 (2002).","journal-title":"J. Neurosci."},{"key":"1348_CR41","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s12264-021-00672-1","volume":"37","author":"W Liedtke","year":"2021","unstructured":"Liedtke, W. STING-ing pain: how can pro-inflammatory signaling attenuate pain? Neurosci. Bull. 37, 1075\u20131078 (2021).","journal-title":"Neurosci. Bull."},{"key":"1348_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108476","volume":"248","author":"J Zhao","year":"2023","unstructured":"Zhao, J., Huh, Y., Bortsov, A., Diatchenko, L. & Ji, R. R. Immunotherapies in chronic pain through modulation of neuroimmune interactions. Pharmacol. Ther. 248, 108476 (2023).","journal-title":"Pharmacol. Ther."},{"key":"1348_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999407","volume":"13","author":"X Jiang","year":"2022","unstructured":"Jiang, X. et al. Interleukin-17 as a potential therapeutic target for chronic pain. Front. Immunol. 13, 999407 (2022).","journal-title":"Front. Immunol."},{"key":"1348_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10787-023-01216-x","volume":"31","author":"AA Atta","year":"2023","unstructured":"Atta, A. A., Ibrahim, W. W., Mohamed, A. F. & Abdelkader, N. F. Microglia polarization in nociplastic pain: mechanisms and perspectives. Inflammopharmacology 31, 1053\u20131067 (2023).","journal-title":"Inflammopharmacology"},{"key":"1348_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1341981","volume":"15","author":"C Selmi","year":"2024","unstructured":"Selmi, C. et al. Pain in axial spondyloarthritis: role of the JAK\/STAT pathway. Front. Immunol. 15, 1341981 (2024).","journal-title":"Front. Immunol."},{"key":"1348_CR46","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/rheumatology\/keaa888","volume":"60","author":"SA Provan","year":"2021","unstructured":"Provan, S. A., Dean, L. E., Jones, G. T. & Macfarlane, G. J. The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology biologics register for ankylosing spondylitis. Rheumatology 60, 4121\u20134129 (2021).","journal-title":"Rheumatology"},{"key":"1348_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002049","volume":"8","author":"IB McInnes","year":"2022","unstructured":"McInnes, I. B. et al. Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials. RMD Open 8, e002049 (2022).","journal-title":"RMD Open"},{"key":"1348_CR48","doi-asserted-by":"publisher","first-page":"668","DOI":"10.55563\/clinexprheumatol\/e7ayu8","volume":"39","author":"N Crispino","year":"2021","unstructured":"Crispino, N. & Ciccia, F. JAK\/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis. Clin. Exp. Rheumatol. 39, 668\u2013675 (2021).","journal-title":"Clin. Exp. Rheumatol."},{"key":"1348_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41584-019-0364-x","volume":"16","author":"E Gracey","year":"2020","unstructured":"Gracey, E. et al. Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis. Nat. Rev. Rheumatol. 16, 193\u2013207 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1348_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06933-4","volume":"9","author":"I Cambre","year":"2018","unstructured":"Cambre, I. et al. Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis. Nat. Commun. 9, 4613 (2018).","journal-title":"Nat. Commun."},{"key":"1348_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003372","volume":"9","author":"P Iyer","year":"2023","unstructured":"Iyer, P., Hwang, M., Ridley, L. & Weisman, M. M. Biomechanics in the onset and severity of spondyloarthritis: a force to be reckoned with. RMD Open 9, e003372 (2023).","journal-title":"RMD Open"},{"key":"1348_CR52","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.3390\/ijms241914924","volume":"24","author":"A Fassio","year":"2023","unstructured":"Fassio, A. et al. Osteoimmunology of spondyloarthritis. Int. J. Mol. Sci. 24, 14924 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1348_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001480","volume":"7","author":"FM Perrotta","year":"2021","unstructured":"Perrotta, F. M., Lories, R. & Lubrano, E. To move or not to move: the paradoxical effect of physical exercise in axial spondyloarthritis. RMD Open 7, e001480 (2021).","journal-title":"RMD Open"},{"key":"1348_CR54","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/art.21444","volume":"53","author":"MM Ward","year":"2005","unstructured":"Ward, M. M., Weisman, M. H., Davis, J. C. Jr. & Reveille, J. D. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum. 53, 710\u2013717 (2005).","journal-title":"Arthritis Rheum."},{"key":"1348_CR55","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjsports-2018-099943","volume":"54","author":"SH Sveaas","year":"2020","unstructured":"Sveaas, S. H. et al. High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients. Br. J. Sports Med. 54, 292\u2013297 (2020).","journal-title":"Br. J. Sports Med."},{"key":"1348_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301965","volume":"19","author":"M Carbo","year":"2024","unstructured":"Carbo, M. et al. Higher levels of physical activity are associated with less evasive coping, better physical function and quality of life in patients with axial spondyloarthritis. PLoS ONE 19, e0301965 (2024).","journal-title":"PLoS ONE"},{"key":"1348_CR57","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","volume":"162","author":"E Kosek","year":"2021","unstructured":"Kosek, E. et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162, 2629\u20132634 (2021).","journal-title":"Pain"},{"key":"1348_CR58","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/key075.533","volume":"57","author":"SJ Duffield","year":"2018","unstructured":"Duffield, S. J., Miller, N., Zhao, S. & Goodson, N. J. Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatology 57, 1453\u20131460 (2018).","journal-title":"Rheumatology"},{"key":"1348_CR59","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1002\/art.40185","volume":"69","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane, G. J. et al. Co-Occurrence and characteristics of patients with axial spondyloarthritis who meet criteria for fibromyalgia: results from a UK national register. Arthritis Rheumatol. 69, 2144\u20132150 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR60","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","volume":"18","author":"N Bello","year":"2016","unstructured":"Bello, N., Etcheto, A., Beal, C., Dougados, M. & Molto, A. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis. Arthritis Res. Ther. 18, 42 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"1348_CR61","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3899\/jrheum.160104","volume":"43","author":"J Wach","year":"2016","unstructured":"Wach, J., Letroublon, M. C., Coury, F. & Tebib, J. G. Fibromyalgia in spondyloarthritis: effect on disease activity assessment in clinical practice. J. Rheumatol. 43, 2056\u20132063 (2016).","journal-title":"J. Rheumatol."},{"key":"1348_CR62","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"77","author":"A Molto","year":"2018","unstructured":"Molto, A. et al. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann. Rheum. Dis. 77, 533\u2013540 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR63","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1093\/rheumatology\/keaf102","volume":"64","author":"SC Kieskamp","year":"2025","unstructured":"Kieskamp, S. C. et al. Interrelationships of disease activity, central sensitization, psychosocial and lifestyle factors in axial spondyloarthritis. Rheumatology 64, 3547\u20133555 (2025).","journal-title":"Rheumatology"},{"key":"1348_CR64","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1093\/rheumatology\/keab019","volume":"60","author":"SC Kieskamp","year":"2021","unstructured":"Kieskamp, S. C. et al. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis. Rheumatology 60, 4476\u20134485 (2021).","journal-title":"Rheumatology"},{"key":"1348_CR65","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10865-016-9782-2","volume":"39","author":"H Leventhal","year":"2016","unstructured":"Leventhal, H., Phillips, L. A. & Burns, E. The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management. J. Behav. Med. 39, 935\u2013946 (2016).","journal-title":"J. Behav. Med."},{"key":"1348_CR66","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13075-018-1626-8","volume":"20","author":"TW Swinnen","year":"2018","unstructured":"Swinnen, T. W., Westhovens, R., Dankaerts, W. & de Vlam, K. Widespread pain in axial spondyloarthritis: clinical importance and gender differences. Arthritis Res. Ther. 20, 156 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"1348_CR67","first-page":"419","volume":"55","author":"C Webers","year":"2016","unstructured":"Webers, C. et al. Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study. Rheumatology 55, 419\u2013428 (2016).","journal-title":"Rheumatology"},{"key":"1348_CR68","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/acr.25103","volume":"75","author":"K Aouad","year":"2023","unstructured":"Aouad, K. et al. Influence of sex on early axial spondyloarthritis: a six-year longitudinal analysis from a large national cohort. Arthritis Care Res. 75, 2107\u20132116 (2023).","journal-title":"Arthritis Care Res."},{"key":"1348_CR69","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3899\/jrheum.2024-0936","volume":"51","author":"YC Lee","year":"2024","unstructured":"Lee, Y. C., Malfait, A. M. & Ogdie, A. R. Unmet needs in spondyloarthritis: understanding and managing chronic pain. J. Rheumatol. 51, 1235\u20131240 (2024).","journal-title":"J. Rheumatol."},{"key":"1348_CR70","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1097\/j.pain.0000000000002104","volume":"162","author":"C Fauchon","year":"2021","unstructured":"Fauchon, C. et al. Sex differences in brain modular organization in chronic pain. Pain 162, 1188\u20131200 (2021).","journal-title":"Pain"},{"key":"1348_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11926-018-0744-2","volume":"20","author":"T Rusman","year":"2018","unstructured":"Rusman, T., van Vollenhoven, R. F. & van der Horst-Bruinsma, I. E. Gender differences in axial spondyloarthritis: women are not so lucky. Curr. Rheumatol. Rep. 20, 35 (2018).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1348_CR72","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1523\/JNEUROSCI.5223-05.2006","volume":"26","author":"YR Smith","year":"2006","unstructured":"Smith, Y. R. et al. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J. Neurosci. 26, 5777\u20135785 (2006).","journal-title":"J. Neurosci."},{"key":"1348_CR73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.pain.2012.11.016","volume":"154","author":"K Vincent","year":"2013","unstructured":"Vincent, K. et al. Brain imaging reveals that engagement of descending inhibitory pain pathways in healthy women in a low endogenous estradiol state varies with testosterone. Pain 154, 515\u2013524 (2013).","journal-title":"Pain"},{"key":"1348_CR74","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1093\/rheumatology\/kex187","volume":"56","author":"S Ibanez Vodnizza","year":"2017","unstructured":"Ibanez Vodnizza, S. et al. Muscle wasting in male TNF-\u03b1 blocker naive ankylosing spondylitis patients: a comparison of gender differences in body composition. Rheumatology 56, 1566\u20131572 (2017).","journal-title":"Rheumatology"},{"key":"1348_CR75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/acr.25512","volume":"77","author":"A Gao","year":"2025","unstructured":"Gao, A. et al. Sex-related differences in efficacy and safety outcomes in axial spondyloarthritis randomized clinical trials: a systematic literature review and meta-analysis. Arthritis Care Res. 77, 813\u2013826\u00a0(2025).","journal-title":"Arthritis Care Res."},{"key":"1348_CR76","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett, S. et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J. Rheumatol. 21, 2286\u20132291 (1994).","journal-title":"J. Rheumatol."},{"key":"1348_CR77","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2010","unstructured":"Machado, P. et al. Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann. Rheum. Dis. 70, 47\u201353 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR78","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/rheumatology\/kex318","volume":"57","author":"X Baraliakos","year":"2018","unstructured":"Baraliakos, X. et al. Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology 57, 1541\u20131547 (2018).","journal-title":"Rheumatology"},{"key":"1348_CR79","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen, R., Baron, R., Gockel, U. & Tolle, T. R. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr. Med. Res. Opin. 22, 1911\u20131920 (2006).","journal-title":"Curr. Med. Res. Opin."},{"key":"1348_CR80","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pain.2003.12.024","volume":"108","author":"D Bouhassira","year":"2004","unstructured":"Bouhassira, D. et al. Development and validation of the neuropathic pain symptom inventory. Pain 108, 248\u2013257 (2004).","journal-title":"Pain"},{"key":"1348_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","volume":"1","author":"R Melzack","year":"1975","unstructured":"Melzack, R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1, 277\u2013299 (1975).","journal-title":"Pain"},{"key":"1348_CR82","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1533-2500.2011.00493.x","volume":"12","author":"TG Mayer","year":"2012","unstructured":"Mayer, T. G. et al. The development and psychometric validation of the central sensitization inventory. Pain. Pract. 12, 276\u2013285 (2012).","journal-title":"Pain. Pract."},{"key":"1348_CR83","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland, C. S. & Ryan, K. M. Pain assessment: global use of the Brief Pain Inventory. Ann. Acad. Med. Singap. 23, 129\u2013138 (1994).","journal-title":"Ann. Acad. Med. Singap."},{"key":"1348_CR84","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/acr.25358","volume":"76","author":"P Mease","year":"2024","unstructured":"Mease, P., Reed, G., Ogdie, A., Pappas, D. A. & Kremer, J. M. Prevalence of fibromyalgia and widespread pain in psoriatic arthritis: association with disease severity assessment in a large US registry. Arthritis Care Res. 76, 1313\u20131321 (2024).","journal-title":"Arthritis Care Res."},{"key":"1348_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003784","volume":"10","author":"K Chaabo","year":"2024","unstructured":"Chaabo, K. et al. Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis. RMD Open 10, e003784 (2024).","journal-title":"RMD Open"},{"key":"1348_CR86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/art.41069","volume":"72","author":"CM Kaplan","year":"2020","unstructured":"Kaplan, C. M. et al. Association of inflammation with pronociceptive brain connections in rheumatoid arthritis patients with concomitant fibromyalgia. Arthritis Rheumatol. 72, 41\u201346 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR87","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3389\/fimmu.2019.03009","volume":"10","author":"AG Vanderwall","year":"2019","unstructured":"Vanderwall, A. G. & Milligan, E. D. Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front. Immunol. 10, 3009 (2019).","journal-title":"Front. Immunol."},{"key":"1348_CR88","doi-asserted-by":"crossref","first-page":"R406","DOI":"10.1152\/ajpcell.1998.274.2.C406","volume":"274","author":"L Kapas","year":"1998","unstructured":"Kapas, L., Hansen, M. K., Chang, H. Y. & Krueger, J. M. Vagotomy attenuates but does not prevent the somnogenic and febrile effects of lipopolysaccharide in rats. Am. J. Physiol. 274, R406\u2013R411 (1998).","journal-title":"Am. J. Physiol."},{"key":"1348_CR89","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer, R., O\u2019Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46\u201356 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"1348_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205769","volume":"13","author":"MA Erickson","year":"2018","unstructured":"Erickson, M. A. et al. Genetics and sex influence peripheral and central innate immune responses and blood-brain barrier integrity. PLoS ONE 13, e0205769 (2018).","journal-title":"PLoS ONE"},{"key":"1348_CR91","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/art.42429","volume":"75","author":"F Sunzini","year":"2023","unstructured":"Sunzini, F., Schrepf, A., Clauw, D. J. & Basu, N. The biology of pain: through the rheumatology lens. Arthritis Rheumatol. 75, 650\u2013660 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2023","unstructured":"Ramiro, S. et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann. Rheum. Dis. 82, 19\u201334 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR93","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/ard-2022-223297","volume":"82","author":"A Ortolan","year":"2023","unstructured":"Ortolan, A. et al. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. Ann. Rheum. Dis. 82, 142\u2013152 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR94","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkae062","volume":"8","author":"MJ Roberts","year":"2024","unstructured":"Roberts, M. J., Hamrouni, M., Linsley, V., Moorthy, A. & Bishop, N. C. Exercise as an anti-inflammatory Therapy in Axial Spondyloarthritis Therapeutic Intervention (EXTASI) study: a randomized controlled trial. Rheumatol. Adv. Pract. 8, rkae062 (2024).","journal-title":"Rheumatol. Adv. Pract."},{"key":"1348_CR95","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13352","volume":"50","author":"X Hu","year":"2020","unstructured":"Hu, X. et al. Effects of exercise programmes on pain, disease activity and function in ankylosing spondylitis: a meta-analysis of randomized controlled trials. Eur. J. Clin. Invest. 50, e13352 (2020).","journal-title":"Eur. J. Clin. Invest."},{"key":"1348_CR96","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3899\/jrheum.2023-0718","volume":"51","author":"X Baraliakos","year":"2024","unstructured":"Baraliakos, X., Bergmann, E., Tsiami, S., Redeker, I. & Braun, J. A good response to nonsteroidal antiinflammatory drugs does not discriminate patients with longstanding axial spondyloarthritis from controls with chronic back pain. J. Rheumatol. 51, 250\u2013256 (2024).","journal-title":"J. Rheumatol."},{"key":"1348_CR97","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/ard-2022-223298","volume":"82","author":"C Webers","year":"2023","unstructured":"Webers, C. et al. Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis. Ann. Rheum. Dis. 82, 130\u2013141 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR98","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0140-6736(24)02263-3","volume":"405","author":"V Navarro-Compan","year":"2025","unstructured":"Navarro-Compan, V., Sepriano, A., Capelusnik, D. & Baraliakos, X. Axial spondyloarthritis. Lancet 405, 159\u2013172 (2025).","journal-title":"Lancet"},{"key":"1348_CR99","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/art.43084","volume":"77","author":"AP Trouvin","year":"2025","unstructured":"Trouvin, A. P. et al. Changes in descending pain modulation during anti-tumor necrosis factor therapy: a prospective study in rheumatoid arthritis and spondyloarthritis. Arthritis Rheumatol. 77, 658\u2013663 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR100","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002253","volume":"8","author":"V Navarro-Compan","year":"2022","unstructured":"Navarro-Compan, V. et al. Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial. RMD Open 8, e002253 (2022).","journal-title":"RMD Open"},{"key":"1348_CR101","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s40744-023-00536-2","volume":"10","author":"V Navarro-Compan","year":"2023","unstructured":"Navarro-Compan, V. et al. Effect of upadacitinib on disease activity, pain, fatigue, function, health-related quality of life and work productivity for biologic refractory ankylosing spondylitis. Rheumatol. Ther. 10, 679\u2013691 (2023).","journal-title":"Rheumatol. Ther."},{"key":"1348_CR102","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13075-024-03313-w","volume":"26","author":"V Navarro-Compan","year":"2024","unstructured":"Navarro-Compan, V. et al. Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis. Arthritis Res. Ther. 26, 105 (2024).","journal-title":"Arthritis Res. Ther."},{"key":"1348_CR103","doi-asserted-by":"publisher","first-page":"h1225","DOI":"10.1136\/bmj.h1225","volume":"350","author":"GC Machado","year":"2015","unstructured":"Machado, G. C. et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ 350, h1225 (2015).","journal-title":"BMJ"},{"key":"1348_CR104","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20966123","volume":"12","author":"C Lopez-Medina","year":"2020","unstructured":"Lopez-Medina, C. & Molto, A. Comorbid pain in axial spondyloarthritis, including fibromyalgia. Ther. Adv. Musculoskelet. Dis. 12, 1759720X20966123 (2020).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"1348_CR105","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/jcm14041294","volume":"14","author":"T Cerasoli","year":"2025","unstructured":"Cerasoli, T. et al. Injective therapies for managing sacroiliac joint pain in spondyloarthropathy: a systematic review and meta-analysis. J. Clin. Med. 14, 1294 (2025).","journal-title":"J. Clin. Med."},{"key":"1348_CR106","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/rheumatology\/keae323","volume":"64","author":"MAT van Wissen","year":"2025","unstructured":"van Wissen, M. A. T. et al. One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations. Rheumatology 64, 1817\u20131825 (2025).","journal-title":"Rheumatology"},{"key":"1348_CR107","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1002\/art.41042","volume":"71","author":"MM Ward","year":"2019","unstructured":"Ward, M. M. et al. 2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network Recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 71, 1599\u20131613 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1348_CR108","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004218","volume":"10","author":"M Garrido-Cumbrera","year":"2024","unstructured":"Garrido-Cumbrera, M. et al. Factors associated with poor mental health in patients with axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS). RMD Open 10, e004218 (2024).","journal-title":"RMD Open"},{"key":"1348_CR109","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/16506073.2015.1098724","volume":"45","author":"MM Veehof","year":"2016","unstructured":"Veehof, M. M., Trompetter, H. R., Bohlmeijer, E. T. & Schreurs, K. M. Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn. Behav. Ther. 45, 5\u201331 (2016).","journal-title":"Cogn. Behav. Ther."},{"key":"1348_CR110","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.2147\/JPR.S144631","volume":"11","author":"A Feliu-Soler","year":"2018","unstructured":"Feliu-Soler, A. et al. Current status of acceptance and commitment therapy for chronic pain: a narrative review. J. Pain. Res. 11, 2145\u20132159 (2018).","journal-title":"J. Pain. Res."},{"key":"1348_CR111","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/JPR.S83653","volume":"9","author":"L Sharpe","year":"2016","unstructured":"Sharpe, L. Psychosocial management of chronic pain in patients with rheumatoid arthritis: challenges and solutions. J. Pain. Res. 9, 137\u2013146 (2016).","journal-title":"J. Pain. Res."},{"key":"1348_CR112","first-page":"CD003968","volume":"9","author":"E Fisher","year":"2018","unstructured":"Fisher, E. et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst. Rev. 9, CD003968 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1348_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152248","volume":"63","author":"J Bidonde","year":"2023","unstructured":"Bidonde, J. et al. Effectiveness of non-pharmacological interventions for fibromyalgia and quality of review methods: an overview of Cochrane Reviews. Semin. Arthritis Rheum. 63, 152248 (2023).","journal-title":"Semin. Arthritis Rheum."},{"key":"1348_CR114","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane, G. J. et al. EULAR revised recommendations for the management of fibromyalgia. Ann. Rheum. Dis. 76, 318\u2013328 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1348_CR115","doi-asserted-by":"publisher","first-page":"24","DOI":"10.64719\/pb.4519","volume":"55","author":"A Malik","year":"2025","unstructured":"Malik, A. et al. Serotonin and norepinephrine reuptake inhibitors (SNRIs) for treatment of fibromyalgia: a comprehensive clinical review. Psychopharmacol. Bull. 55, 24\u201340 (2025).","journal-title":"Psychopharmacol. Bull."},{"key":"1348_CR116","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.3899\/jrheum.110194","volume":"38","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky, H., Harris, H. W., Archambault, W. T., Kwong, T. & Lederman, S. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study. J. Rheumatol. 38, 2653\u20132663 (2011).","journal-title":"J. Rheumatol."},{"key":"1348_CR117","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/acr.25142","volume":"75","author":"S Lederman","year":"2023","unstructured":"Lederman, S., Arnold, L. M., Vaughn, B., Kelley, M. & Sullivan, G. M. Efficacy and safety of sublingual cyclobenzaprine for the treatment of fibromyalgia: results from a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. 75, 2359\u20132368 (2023).","journal-title":"Arthritis Care Res."},{"key":"1348_CR118","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pain.2009.05.014","volume":"145","author":"W Hauser","year":"2009","unstructured":"Hauser, W., Bernardy, K., Uceyler, N. & Sommer, C. Treatment of fibromyalgia syndrome with gabapentin and pregabalin \u2014 a meta-analysis of randomized controlled trials. Pain 145, 69\u201381 (2009).","journal-title":"Pain"},{"key":"1348_CR119","doi-asserted-by":"publisher","first-page":"j3221","DOI":"10.1136\/bmj.j3221","volume":"358","author":"SP Cohen","year":"2017","unstructured":"Cohen, S. P. & Hooten, W. M. Advances in the diagnosis and management of neck pain. BMJ 358, j3221 (2017).","journal-title":"BMJ"},{"key":"1348_CR120","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1932296820951829","volume":"16","author":"MD Staudt","year":"2022","unstructured":"Staudt, M. D. et al. Current strategies for the management of painful diabetic neuropathy. J. Diabetes Sci. Technol. 16, 341\u2013352 (2022).","journal-title":"J. Diabetes Sci. Technol."},{"key":"1348_CR121","volume":"2013","author":"KA Kontoangelos","year":"2013","unstructured":"Kontoangelos, K. A. et al. Pregabalin for opioid-refractory pain in a patient with ankylosing spondylitis. Case Rep. Psychiatry 2013, 912409 (2013).","journal-title":"Case Rep. Psychiatry"},{"key":"1348_CR122","first-page":"123","volume":"22","author":"AH Onutu","year":"2015","unstructured":"Onutu, A. H. Duloxetine, an antidepressant with analgesic properties \u2014 a preliminary analysis. Rom. J. Anaesth. Intensive Care 22, 123\u2013128 (2015).","journal-title":"Rom. J. Anaesth. Intensive Care"},{"key":"1348_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2024.1398442","volume":"5","author":"S Ayub","year":"2024","unstructured":"Ayub, S. et al. Non-opioid psychiatric medications for chronic pain: systematic review and meta-analysis. Front. Pain. Res. 5, 1398442 (2024).","journal-title":"Front. Pain. Res."},{"key":"1348_CR124","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1302\/0301-620X.104B5.BJJ-2021-1816.R1","volume":"104-B","author":"ZM Borton","year":"2022","unstructured":"Borton, Z. M., Oakley, B. J., Clamp, J. A., Birch, N. C. & Bateman, A. H. Cervical transforaminal epidural steroid injections for radicular pain: a systematic review. Bone Jt J. 104-B, 567\u2013574 (2022).","journal-title":"Bone Jt J."},{"key":"1348_CR125","first-page":"179","volume":"25","author":"L Manchikanti","year":"2022","unstructured":"Manchikanti, L. et al. Equivalent outcomes of lumbar therapeutic facet joint nerve blocks and radiofrequency neurotomy: comparative evaluation of clinical outcomes and cost utility. Pain. Physician 25, 179\u2013192 (2022).","journal-title":"Pain. Physician"},{"key":"1348_CR126","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/ner.13020","volume":"23","author":"M Hofmeister","year":"2020","unstructured":"Hofmeister, M. et al. Effectiveness of neurostimulation technologies for the management of chronic pain: a systematic review. Neuromodulation 23, 150\u2013157 (2020).","journal-title":"Neuromodulation"},{"key":"1348_CR127","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ard.2025.01.035","volume":"84","author":"D Poddubnyy","year":"2025","unstructured":"Poddubnyy, D. et al. The Assessment of SpondyloArthritis international Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis. Ann. Rheum. Dis. 84, 538\u2013546 (2025).","journal-title":"Ann. Rheum. Dis."}],"updated-by":[{"DOI":"10.1038\/s41584-026-01363-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000}}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01348-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01348-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:02:23Z","timestamp":1772067743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-025-01348-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1038\/s41584-025-01348-0","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"15 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41584-026-01363-9","URL":"https:\/\/doi.org\/10.1038\/s41584-026-01363-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.B. has consulted for and\/or participated in scientific advisory boards for AbbVie, Advanz, Alexion, Alphasigma, Amgen, AstraZeneca, BMS, CESAS, Celltrion, Clarivate, Dr. Reddy\u2019s, Galapagos, Greywolfe, Globemed, Johnson and Johnson, Lilly, Moonlake, Novartis, Peervoice, Pfizer, Roche, Sandoz, Springer, STADA, Takeda, UCB and Zuellig; has received research grants from AbbVie, Celltrion, Janssen, Moonlake and Novartis; is EULAR president and past president of ASAS. V.N.-C. has consulted for and\/or participated in scientific advisory boards for AbbVie, Alfasigma, BMS, Galapagos, Eli Lilly, Johnson and Johnson, Moonlake, Novartis, Pfizer, Roche and UCB; has received research grants from AbbVie and Novartis; is also the president of ASAS. N.Z. has received speaker fees from Roche, AbbVie, Eli Lilly, Pfizer, Janssen, Novartis, Pierre Fabre, Apotex and Pharmaline; has participated in advisory boards for Roche, AbbVie, Eli Lilly, Pfizer, Janssen, Novartis, Gilead and NewBridge; has received research grants from AbbVie, NewBridge, Pfizer and Algorithm\/Celgene. D.P. has received research support from AbbVie, Eli Lilly, Johnson and Johnson, Novartis, Pfizer and UCB; has received consulting fees from AbbVie, Eli Lilly, GlaxoSmithKline, Greywolf Therapeutics, Johnson and Johnson, Merk, Moonlake, Novartis, Pfizer and UCB; has received speaker fees from AbbVie, Canon, Celltrion, Eli Lilly, Globemed, Johnson and Johnson, Medscape, Novartis, Peervoice, Pfizer and UCB; serves as a member of the executive committee of ASAS and is a member of the steering committee of GRAPPA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}